KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes... << Prices as on Oct 14, 2024 >>  ABB India 8566.2  [ 0.21% ]  ACC 2317.55  [ 0.17% ]  Ambuja Cements 588.55  [ 0.56% ]  Asian Paints Ltd. 3039.9  [ 0.05% ]  Axis Bank Ltd. 1164.4  [ -0.68% ]  Bajaj Auto 11892.85  [ 0.12% ]  Bank of Baroda 244.6  [ 0.95% ]  Bharti Airtel 1696.6  [ 0.57% ]  Bharat Heavy Ele 268.7  [ -0.41% ]  Bharat Petroleum 340.2  [ 0.73% ]  Britannia Ind. 5971.3  [ -0.11% ]  Cipla 1599.8  [ 0.29% ]  Coal India 498.35  [ 1.09% ]  Colgate Palm. 3518.8  [ -4.62% ]  Dabur India 567.3  [ -0.61% ]  DLF Ltd. 862.35  [ 1.76% ]  Dr. Reddy's Labs 6664.65  [ 0.96% ]  GAIL (India) 230.7  [ 0.52% ]  Grasim Inds. 2728.9  [ 0.12% ]  HCL Technologies 1856  [ 0.89% ]  HDFC 2729.95  [ -0.62% ]  HDFC Bank 1688.5  [ 2.32% ]  Hero MotoCorp 5554.85  [ 1.43% ]  Hindustan Unilever L 2789  [ 0.30% ]  Hindalco Indus. 742.75  [ -0.61% ]  ICICI Bank 1232  [ 0.75% ]  IDFC L 108  [ -1.77% ]  Indian Hotels Co 704.9  [ -0.55% ]  IndusInd Bank 1370.6  [ 1.70% ]  Infosys L 1958.7  [ 1.22% ]  ITC Ltd. 496.85  [ 1.72% ]  Jindal St & Pwr 994.4  [ -1.11% ]  Kotak Mahindra Bank 1910.3  [ 1.47% ]  L&T 3553.35  [ 2.02% ]  Lupin Ltd. 2243.15  [ 0.88% ]  Mahi. & Mahi 3158.35  [ 0.75% ]  Maruti Suzuki India 12538.45  [ -1.85% ]  MTNL 53.46  [ 4.97% ]  Nestle India 2502.9  [ -0.38% ]  NIIT Ltd. 175.95  [ 5.01% ]  NMDC Ltd. 237  [ 1.56% ]  NTPC 424.35  [ 0.45% ]  ONGC 286.5  [ -2.05% ]  Punj. NationlBak 104.95  [ 0.00% ]  Power Grid Corpo 330.75  [ 0.23% ]  Reliance Inds. 2745.2  [ 0.11% ]  SBI 805.25  [ 0.66% ]  Vedanta 499.05  [ 0.33% ]  Shipping Corpn. 239.15  [ -1.95% ]  Sun Pharma. 1909.55  [ 0.40% ]  Tata Chemicals 1102.95  [ -6.87% ]  Tata Consumer Produc 1113.4  [ 0.02% ]  Tata Motors 928.05  [ -0.31% ]  Tata Steel 158.3  [ -1.49% ]  Tata Power Co. 462.35  [ 0.29% ]  Tata Consultancy 4136.65  [ -0.34% ]  Tech Mahindra 1692.75  [ 2.86% ]  UltraTech Cement 11311.1  [ -0.97% ]  United Spirits 1539.5  [ 1.26% ]  Wipro 549.45  [ 3.88% ]  Zee Entertainment En 131.2  [ 0.85% ]  

Company Information

Indian Indices

  • Loading....

Global Indices

  • Loading....

Forex

  • Loading....

CIPLA LTD.

14 October 2024 | 12:00

Industry >> Pharmaceuticals

Select Another Company

ISIN No INE059A01026 BSE Code / NSE Code 500087 / CIPLA Book Value (Rs.) 330.69 Face Value 2.00
Bookclosure 02/08/2024 52Week High 1702 EPS 51.03 P/E 31.32
Market Cap. 129090.09 Cr. 52Week Low 1132 P/BV / Div Yield (%) 4.83 / 0.81 Market Lot 1.00
Security Type Other

AUDITOR'S REPORT

You can view full text of the latest Director's Report for the company.
Year End :2024-03 

1. We have audited the accompanying standalone financial statements of Cipla Limited ('the Company'), which comprise the Balance Sheet as at 31 March 2024, the Statement of Profit and Loss (including Other Comprehensive Income), the Statement of Cash Flow and the Statement of Changes in Equity for the year then ended and notes to the standalone financial statements, including material accounting policy information and other explanatory information.

2. In our opinion and to the best of our information and according to the explanations given to us, the aforesaid standalone financial statements give the information required by the Companies Act, 2013 ('the Act') in the manner so required and give a true and fair view in conformity with the Indian Accounting Standards ('Ind AS') specified under section 133 of the Act read with the Companies (Indian Accounting Standards) Rules, 2015 and other accounting principles generally accepted in India, of the state of affairs of the Company as at 31 March 2024 and its profit (including other comprehensive income), its cash flows and the changes in equity for the year ended on that date.

Basis for Opinion

3. We conducted our audit in accordance with the Standards on Auditing specified under section 143(10) of the Act Our responsibilities under those standards are further described in the Auditor's Responsibilities for the Audit of the Standalone Financial Statements section of our report We are independent of the Company in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India ('ICAI') together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Act and the rules thereunder and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

4. Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the standalone financial statements of the current period. These matters were addressed in the context of our audit of the financial statements as a whole and in forming our opinion thereon and we do not provide a separate opinion on these matters.

5. We have determined the matters described below to the key audit matters to be communicated in our report

Key audit matters

How our audit addressed the key audit matters

DPCO matters:

The Company has received various notices of demand from the National Pharmaceutical Pricing Authority (NPPA), Government of India, on account of alleged overcharging in respect of certain drugs under the Drugs (Prices Control) Orders (DPCO) in various years. The total demand against the Company as stated in NPPA public disclosure amounts to Rs. 3707 crores, as disclosed in note 38B to the standalone financial statements, of which there are :

a) Matters pending at Honourable Bombay High Court, wherein the Holding Company has deposited H 175.08 crore being 50% of the total demand of H 350.15 crore as at 1 August 2003 under protest pursuant to direction of Honourable Supreme Court of India; and

b) Other matters wherein based on facts and legal advice, the Company has recorded a charge of H 19.90 crores (including interest) during the year ended 31 March 2024 and carries a total provision of H 80.78 crores (including interest) as at 31 March 2024.

Our audit of DPCO matters included, but was not limited to, the

following procedures:

a) Obtained an understanding of the management's process for updating the status of the matters, assessment of accounting treatment in accordance with Ind AS 37 and for measurement of amounts involved;

b) Evaluated the design and tested the operating effectiveness of key controls around above process;

c) Inspected correspondence with the Company's external legal counsel in order to corroborate our understanding of these matters, accompanied by discussions with both internal and external legal counsels. Tested the objectivity and competence of such management experts involved;

d) Obtained direct confirmation from the external legal counsel handling DPCO matters with respect to the legal determination of the liability arising from such matters, conclusion of the matters in accordance with the requirements of Ind AS 37 and disclosures to be made in the financial statements. Evaluated the response received from the external legal counsel to ensure that the conclusions reached are supported by sufficient legal rationale;

Key audit matters

How our audit addressed the key audit matters

The amounts involved are material and the application of

e) Assessed the appropriateness of methods used and the reliability

accounting principles as given under Ind AS 37, Provisions,

of underlying data for the calculations made for quantifying

Contingent Liabilities and Contingent Assets ('Ind AS 37'),

the amounts involved. Tested the arithmetical accuracy of such

in order to determine the amounts to be recognised as

calculations; and

liability or to be disclosed as a contingent liability or not,

f) Evaluated the adequacy of disclosures given in the standalone

is inherently subjective and needs careful evaluation and

financial statements, including disclosure of the significant litigations

significant judgement to be applied by the management

of the Company, in accordance with applicable accounting

Considering the materiality and the inherent subjectivity

standards.

which involves significant management judgment in

Based on the audit procedures performed, the judgements made by

predicting the outcome of the matter,

the management were reasonable and disclosures made in respect

DPCO matters have been considered to be a key audit

of these matters were appropriate in the context of the standalone

matter for the current period audit

financial statements taken as a whole.

Recoverability of investments in subsidiaries (Refer note 5):

Our audit included, but was not limited to, the following procedures:

The Company has investments of H 9,264.31 crores in

a) Obtained an understanding of the management's process for

subsidiaries being carried at cost in accordance with

identification of impairment indicators and tested the design and

Ind AS 27, Separate Financial Statements. The Company

operating effectiveness of internal controls over such identification

assesses the recoverable amounts of each investment

and impairment measurement through fair valuation of identified

when impairment indicators exist by comparing the fair

investments;

value (less costs of disposal) and carrying amount of that

b) Involved auditor's experts to assess the appropriateness of the

investment as on the reporting date.

valuation methodologies used by the management;

Management's assessment of whether there are

c) Reconciled the cash flows to the business plans approved by the

impairment indications and estimate of the recoverable amounts of the identified investments determined through discounted cash flow valuation method requires significant

respective Board of Directors of the identified investee companies; d) Evaluated and challenged management's assumptions such as implied growth rates during explicit period, terminal growth rate,

judgment in carrying out the impairment assessment. The key assumptions used in management's assessment of the recoverable amounts include, but are not limited to,

targeting savings and discount rate for their appropriateness based on our understanding of the business of the respective investee companies, past results and external factors such as

projections of future cash flows, growth rates, discount rates, estimated future operating and capital expenditure.

industry trends and forecasts;

Changes to these assumptions could lead to material

e) Obtained and evaluated sensitivity analysis performed by the

changes in estimated recoverable amounts, resulting in

management on key assumptions of implied growth rates during

either impairment or reversals of impairment taken in prior

explicit period, terminal growth rates and discount rates;

years.

f) Tested the mathematical accuracy of the management

Considering the materiality and the inherent subjectivity

computations with regard to cash flows and sensitivity analysis;

which involves significant management judgment in

g) Performed independent sensitivity analysis of aforesaid key

predicting future cash flow projections, recoverability of

assumptions to assess the effect of reasonably possible variations

investments in subsidiaries has been considered to be a

on the current estimated recoverable amount for each of the

key audit matter for the current period audit

identified investments to evaluate sufficiency of headroom between recoverable value and carrying amount; and

h) Evaluated the adequacy of disclosures given in the standalone financial statements, including disclosure of significant assumptions, judgements and sensitivity analysis performed, in accordance with applicable accounting standards.

Based on the audit procedures performed, we determined that the management's assertion on the recoverability of investments in subsidiaries is appropriate in the context of the standalone financial statements taken as a whole.

Key audit matters

How our audit addressed the key audit matters

Revenue from operations: (refer note 1.3.9 and 26 to the

Our audit included, but was not limited to, the following procedures:

Standalone financial statements)

a)

Obtained an understanding of the management's process

The Company recognizes revenue from the sales of

for revenue recognition (from sale to customers, out-licensing

pharmaceutical products to resellers or distributors,

arrangements and service fee), judgments in estimation and

service fee and out-licensing arrangements. The Company

accounting treatment of discount, the right to returns, rebates,

records product sales net of estimated discounts, the right

other price adjustments and regulatory compliance requirements;

to returns, rebates and other price adjustments. The actual

b)

Evaluated the design and tested the operating effectiveness of

point in time when revenue is recognised varies depending

the Company's internal controls, including general IT controls,

on the specific terms and conditions of the sales contracts

key IT application controls exercised by the management, over

entered with customers.

recognition of revenue and measurement of various discount, the

Further, the Company has a large number of customers

right to returns, rebates and other price adjustments;

operating in various geographies and sales contracts with

c)

Evaluated the terms of the licensing arrangements to determine

customers have different terms relating to the recognition

satisfaction of performance obligations under the contracts

of revenue leading to material deductions from gross sales

for appropriate revenue recognition and tested allocation of

which includes discounts, the right to return, rebates and

consideration between performance obligations to verify deferral

other price adjustments.

of revenue in respect of unsatisfied performance obligations;

We identified recognition of revenue from operations as a

d)

Performed substantive testing by selecting samples of revenue

key audit matter because:

transactions pertaining to sale of products during the year and

a) Accrual towards discounts, the right to returns, rebates

during specific periods before and after the year-end. For the

and other price adjustments is complex and requires

samples selected, verified the underlying supporting documents

significant judgments and estimates in relation to

including contracts, agreements, sales invoices and dispatch/

contractual agreements/ commercial terms across

shipping documents to ensure that the correct amount of revenue

various geographies. Any change in these estimates

is recorded in the correct period;

can have a significant financial impact

e)

Obtained management workings for amounts recognised towards

b) The nature of out-licensing contracts are often

discount schemes, the right to returns and rebates and other price

inherently complex and unusual, requiring significant

adjustments during the year and as at year end. On a sample

management judgment to be applied in respect of

basis, tested the underlying calculations for amounts recorded as

revenue recognition.

accruals and provisions towards the aforementioned obligations,

c) The Company considers revenue as key benchmark

as per the terms of related schemes, contracts and regulations and

for evaluating performances and hence, there is risk of

traced the underlying data to source documents;

revenue being overstated due to pressure to achieve

f)

Evaluated historical accuracy of the Company's estimates of year-

targets, earning expectations or incentive schemes

end accruals pertaining to aforesaid arrangements made in the

linked to performance for a reporting period.

g)

previous years to identify any management bias;

Tested unusual non-standard journal entries based on certain criteria's which impacts revenue recognized during the year;

h)

Tested all the manual sales-related adjustments made to revenue comprising of variable consideration under Ind AS 115 to ensure the appropriateness of revenue recognition during the year; and

i)

Evaluated the adequacy of disclosures given in the standalone financial statements in accordance with applicable accounting standards.

Based on audit procedures performed, we determined that the revenue recognition and measurement is appropriate in the context of the standalone financial statements taken as a whole.

Information other than the Financial Statements and Auditor's Report thereon

6. The Company's Board of Directors are responsible for the other information. The other information comprises the information included in the Annual Report, but does not include the standalone financial statements and our auditor's report thereon.

Our opinion on the standalone financial statements does not cover the other information and we do not express any form of assurance conclusion thereon.

In connection with our audit of the standalone financial statements, our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the standalone financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact We have nothing to report in this regard.

Responsibilities of Management and Those Charged with Governance for the Standalone Financial Statements

7 The accompanying standalone financial statements have been approved by the Company's Board of Directors. The Company's Board of Directors are responsible for the matters stated in section 134(5) of the Act with respect to the preparation and presentation of these standalone financial statements that give a true and fair view of the financial position, financial performance including other comprehensive income, changes in equity and cash flows of the Company in accordance with the Ind AS specified under section 133 of the Act and other accounting principles generally accepted in India. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the financial statements that give a true and fair view and are free from material misstatement, whether due to fraud or error.

8. In preparing the financial statements, the Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intend to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

9. Those Board of Directors are also responsible for overseeing the Company's financial reporting process.

Auditor's Responsibilities for the Audit of the Standalone Financial Statements

10. Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with Standards on Auditing will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

11. As part of an audit in accordance with Standards on Auditing, specified under section 143(10) of the Act we exercise professional judgment and maintain professional skepticism throughout the audit We also:

• Identify and assess the risks of material misstatement of the financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control;

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under section 143(3) (i) of the Act we are also responsible for expressing our opinion on whether the Company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls;

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management;

• Conclude on the appropriateness of Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report However, future events or conditions may cause the Company to cease to continue as a going concern; and

• Evaluate the overall presentation, structure and content of the financial statements, including the disclosures and whether the financial statements represent the

underlying transactions and events in a manner that achieves fair presentation.

12. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit

13. We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence and where applicable, related safeguards.

14. From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the financial statements of the current period and are therefore the key audit matters. We describe these matters in our auditor's report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

Report on Other Legal and Regulatory Requirements

15. As required by section 197(16) of the Act based on our audit, we report that the Company has paid remuneration to its directors during the year in accordance with the provisions of and limits laid down under section 197 read with Schedule V to the Act

16. As required by the Companies (Auditor's Report) Order, 2020 ('the Order') issued by the Central Government of India in terms of section 143(11) of the Act we give in the Annexure I, a statement on the matters specified in paragraphs 3 and 4 of the Order, to the extent applicable.

17 Further to our comments in Annexure I, as required by section 143(3) of the Act based on our audit, we report, to the extent applicable, that:

a) We have sought and obtained all the information and explanations which to the best of our knowledge and belief were necessary for the purpose of our audit of the accompanying standalone financial statements;

b) In our opinion, proper books of account as required by law have been kept by the Company so far as it appears from our examination of those books, including the manner prescribed in Rule 3(1) of Companies (Accounts) Rules, 2014, except that the audit trail feature was not enabled at the database level as further stated in paragraph 17(h) (vi) below on reporting under Rule 11(g) of the Companies (Audit and Auditors) Rules, 2014 (as amended).

c) The standalone financial statements dealt with by this report are in agreement with the books of account;

d) In our opinion, the aforesaid standalone financial statements comply with Ind AS specified under section 133 of the Act;

e) On the basis of the written representations received from the directors and taken on record by the Board of Directors, none of the directors is disqualified as on 31 March 2024 from being appointed as a director in terms of section 164(2) of the Act;

f) With respect to the maintenance of accounts and other matters connected therewith refer to our comments in paragraph 17(b) above on reporting under Section 143(3)(b) of the Act and paragraph 17(h)(vi) below on reporting under rule 11(g) of the of the Companies (Audit and Auditors) Rules, 2014 (as amended).

g) With respect to the adequacy of the internal financial controls with reference to financial statements of the Company as on 31 March 2024 and the operating effectiveness of such controls, refer to our separate Report in Annexure II wherein we have expressed an unmodified opinion; and

h) With respect to the other matters to be included in the Auditor's Report in accordance with rule 11 of the Companies (Audit and Auditors) Rules, 2014 (as amended), in our opinion and to the best of our information and according to the explanations given to us:

i. The Company, as detailed in note 38 to the standalone financial statements, has disclosed the impact of pending litigations on its financial position as at 31 March 2024;

ii. As detailed in note 52, the Company did not have any long-term contracts including derivative contracts for which there were any material foreseeable losses as at 31 March 2024;

iii. There has been no delay in transferring amounts, required to be transferred, to the Investor Education and Protection Fund by the Company during the year ended 31 March 2024;

iv a. The management has represented that, to the best of its knowledge and belief, other than as disclosed in note 44(j) and note 44(k) to the standalone financial statements, no funds have been advanced or loaned or invested (either from borrowed funds or securities premium or any other sources or kind of funds) by the Company to or in any person(s) or entity(ies), including foreign entities ('the intermediaries'), with the understanding, whether recorded in writing or otherwise, that the intermediary shall, whether, directly or indirectly lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Company ('the Ultimate Beneficiaries') or

provide any guarantee, security or the like on behalf the Ultimate Beneficiaries;

b. The management has represented that, to the best of its knowledge and belief, as disclosed in note 44(f) to the standalone financial statements, no funds have been received by the Company from any person(s) or entity(ies), including foreign entities ('the Funding Parties'), with the understanding, whether recorded in writing or otherwise, that the Company shall, whether directly or indirectly, lend or invest in other persons or entities identified in any manner whatsoever by or on behalf of the Funding Party ('Ultimate Beneficiaries') or provide any guarantee, security or the like on behalf of the Ultimate Beneficiaries; and

c. Based on such audit procedures performed as considered reasonable and appropriate in the circumstances, nothing has come to our notice that has caused us to believe that the management representations under sub-clauses (a) and (b) above contain any material misstatement.

v. a. The final dividend paid by the Company during the year ended 31 March 2024 in respect of such dividend declared for the previous year is in accordance with section 123 of the Act to the extent it applies to payment of dividend.

b. As stated in note 47 B(b) to the accompanying standalone financial statements, the Board of Directors of the Company have proposed final dividend for the year ended 31 March

2024 which is subject to the approval of the members at the ensuing Annual General Meeting. The dividend declared is in accordance with section 123 of the Act to the extent it applies to declaration of dividend.

vi. Based on examination which included test checks, the Company in respect of financial year commencing on 1 April 2023, has used an accounting software for maintaining its books of account which has a feature of recording audit trail (edit log) facility at the application level of the accounting software and the same has been operated throughout the year for all relevant transactions recorded in the software. Further, during the course of our audit we did not come across any instance of such audit trail features being tampered with. The Audit trail feature (edit log) at the database level for the direct changes was not enabled, however, the Company had adequate controls in the accounting software such as strict user rights and access of administrator log in through the application layer.

For Walker Chandiok & Co LLP

Chartered Accountants

Firm's Registration No.: 001076N/N500013

Gautam Wadhera

Partner

Membership No.: 508835

UDIN: 24508835BKFFCO6403

Place: Mumbai

Date: 10 May 2024